Dedicated to advancing women's health.

Women's health conditions have not received the attention they deserve.
At DotLab, we're changing that.

DotLab | Real Patients with Endometriosis

Our Mission

We're on a mission to advance women's healthcare into an era of precision medicine by developing breakthrough, actionable technologies that lead to better health outcomes for women.

“Oxford Housewife Wins Nobel Prize.”
‍
‍
Such was the headline in 1964 when Dorothy “Dot” Crowfoot Hodgkin won the Nobel Prize in Chemistry for her defining work in X-ray crystallography. Regardless of the headlines, we know that her achievements led to many discoveries in biochemistry and medicine.

Just as Dorothy Hodgkin’s pioneering work brought crystallography into a new age, DotLab was created to bring innovation to women’s healthcare.

To us, a “dot” represents a strong sense of integrity, equality, purpose, and leadership. It also represents the moments in time when clarity can make significant change. DotLab was created in response to problems women face in the healthcare system.

The DotLab team and scientific advisory board are composed of experts in women’s health and technology, and they share a vision of closing the innovation gap in women’s healthcare through precision medicine.

DotLab | Real Patients with DotEndo Test Box

Our first product, DotEndoTM, is designed to make earlier detection of endometriosis possible. 

DotEndo is a breakthrough test that analyzes the expression of microRNA biomarkers associated with endometriosis to provide a clear positive or negative result, not a risk profile.
‍
DotEndo was developed based on over a decade of peer-reviewed scientific research and development.

Our work maps the molecular components of prevalent women’s health issues to create novel tests for quicker diagnosis and better outcomes. 

Clinical Studies

Enrollment concluded

EMPOWER Study

The EMPOWER Study is a prospective, observational, multi-center cohort study enrolling females of reproductive potential aged 18-49 who have been referred to undergo laparotomy or laparoscopy or other procedures for suspected endometriosis and other benign gynecological indications.
Contact

Earliest Science and Publications

Accurate Diagnosis of Endometriosis Using Serum MicroRNAs (2020)

Published in the American Journal of Obstetrics and Gynecology. This peer-reviewed publication demonstrates that 6 microRNA biomarkers can reliably identify endometriosis with high accuracy.
More

Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis (2016)

More

Circulating microRNAs as potential biomarkers for endometriosis (2015)

More

Our Team

Sign up to receive important updates:
DotLab will never share your information with third parties. We respect your privacy. We will only use this information to contact you. See our Privacy Policy for more information about how we collect and use personal data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.